Side by side: size, value over time, results, valuation, margins, growth, debt and shareholder returns, and any of thirty figures charted over the years (up to 6).
Open these as a peer group: up to 12 companies with suggested peers, each company's rank in the group and percentile in its sector and country, saved for you or your team.
From Jan 2020: how each company's value moved, whatever its size.
US$ billions, as reported in each year's annual results.
Revenue of the fiscal year. US dollars at each year's exchange rate.
| Measure | CareDx, Inc✕ CDNA · #4,672 in the world | Celcuity Inc.✕ CELC · #4,529 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Diagnostics and Research | Diagnostics and Research |
| Founded | 1998 | 2011 |
| Size | ||
| Market cap | $3.4 B | |
The largest companies, each against its nearest peers in value from the same industry.
| Fiscal year | CareDx, Inc | Celcuity Inc. |
|---|---|---|
| 2025 | $380 MSEC | — |
| 2024 | $334 MSEC | — |
| 2023 | $280 MSEC | — |
| 2022 | $322 MSEC | — |
| 2021 | $296 MSEC | — |
| 2020 | $192 MSEC | — |
| 2019 | $127 MSEC | — |
| 2018 | $77 MSEC | — |
| 2017 | $48 MSEC | — |
| 2016 | $41 MSEC | — |
| 2015 | $28 MSEC | — |
| 2014 | $27 MSEC | — |
Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports; Ed. = the company's report (editors); WD = Wikidata, citing the annual report; Cap = value.today market caps. Hover a figure for its period.
| $3.5 B |
| Revenue | $380 M | — |
|---|
| Net income | $-21 M▲ best | $-177 M |
|---|
| Employees | 645 | 155 |
|---|
| Valuation | ||
|---|---|---|
| P/E ratio | 26.1× | — |
| Price to sales | 6.8× | — |
| Price to book | 11.1× | 35.2× |
| Free cash flow yield | -0.2%▲ best | -4.3% |
| Profitability | ||
|---|---|---|
| Operating margin | -8.1% | — |
| Net margin | -5.6% | — |
| Return on equity | -6.3%▲ best | -163.8% |
| Growth | ||
|---|---|---|
| Revenue growth | 13.8% | — |
| Revenue growth, 3 years a year | 5.7% | — |
| Financial strength | ||
|---|---|---|
| Debt to equity | — | 1.4× |
| Interest cover | — | -12.0× |
| Shareholder returns | ||
|---|---|---|
| Shareholder yield | 2.6% | — |
| Altman Z-score zone | safe | — |
|---|
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
|---|
Market caps from exchange data or SEC filings on the date shown (* last known value, no current one); revenue and net income from the latest annual results; ratios worked out from each company's own statements for the fiscal year shown. ▲ marks the best of these companies where higher or lower is better; size and valuation multiples are marked for no one. Definitions: methodology.